ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,490Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 16

$1.57M Total Retail Price of All Prescriptions

Rank: 3 out of 16

555 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 555 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

27% of this provider’s 555 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

2% of this provider’s 22,400 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 37.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LEVOTHYROXINE SODIUM 1,027 922 1 1
HYDROCODONE-ACETAMINOPHEN 883 814 S3 2 3
POTASSIUM CHLORIDE 838 780 3 6
FUROSEMIDE 749 695 4 2
LISINOPRIL 649 593 5 4
DONEPEZIL HCL 505 505 6 11
AMLODIPINE BESYLATE 487 431 7 7
CITALOPRAM HBR 486 457 8 16
SIMVASTATIN 475 409 9 5
RANITIDINE HCL 449 400 10 17
OMEPRAZOLE 416 360 11 8
LANTUS 403 363 12 23
NAMENDA 376 376 13 14
GABAPENTIN 375 318 14 12
WARFARIN SODIUM 365 321 15 9
METFORMIN HCL 355 307 16 15
METOPROLOL TARTRATE 354 329 17 10
FENTANYL 350 312 S2 18 30
TRAMADOL HCL 348 293 19 19
TRAZODONE HCL 330 233 20 20
MIRTAZAPINE 296 288 21 13
CARVEDILOL 269 250 22 18
MORPHINE SULFATE ER 260 216 S2 23 69
TAMSULOSIN HCL 237 198 24 29
CYMBALTA 226 177 25 37
POLYETHYLENE GLYCOL 3350 222 210 26 31
SPIRIVA 220 180 27 58
ATORVASTATIN CALCIUM 207 144 28 27
CARBIDOPA-LEVODOPA 201 190 29 45
HYDROCHLOROTHIAZIDE 200 171 30 25
NYSTOP 197 150 31 66
ZOLPIDEM TARTRATE 195 161 32 32
BUSPIRONE HCL 190 176 33 55
CLONIDINE HCL 187 143 34 41
METOCLOPRAMIDE HCL 164 101 35 94
GENERLAC 162 108 36 120
NEXIUM 156 145 37 47
ALENDRONATE SODIUM 154 149 38 38
NOVOLOG 151 132 39 65
QUETIAPINE FUMARATE 150 98 40 36
ISOSORBIDE MONONITRATE ER 146 136 41 35
SEROQUEL 145 114 42 68
TRIAMCINOLONE ACETONIDE 144 115 43 76
LIDODERM 139 129 44 59
DIVALPROEX SODIUM 138 129 45 39
METOPROLOL SUCCINATE 137 124 46 24
PROMETHAZINE HCL 135 108 R 47 101
BUMETANIDE 131 119 48 79
ESCITALOPRAM OXALATE 125 123 49 22
LOVASTATIN 125 100 49 40
FLUTICASONE PROPIONATE 124 85 51 61
ADVAIR DISKUS 123 102 52 56
CLOPIDOGREL 123 123 52 28
JANUVIA 122 114 54 97
FAMOTIDINE 121 106 55 54
DETROL LA 119 88 56 161
SERTRALINE HCL 118 92 57 21
PLAVIX 116 111 58 46
GLYBURIDE 112 112 R 59 109
FLUOXETINE HCL 108 80 60 63
DIGOXIN 104 104 61 48
CIPROFLOXACIN HCL 103 86 62 76
DIOVAN 103 103 62 60
MORPHINE SULFATE 101 54 S2 64 102
LOSARTAN POTASSIUM 101 101 64 34
NAPROXEN 101 58 64 105
ATENOLOL 99 82 67 26
PANTOPRAZOLE SODIUM 98 67 68 44
AGGRENOX 98 98 68 104
DIVALPROEX SODIUM ER 98 67 68 117
METOLAZONE 97 97 71 116
CLOTRIMAZOLE 94 71 72 177
ABILIFY 91 61 73 95
RISPERIDONE 90 77 74 43
HUMULIN R 90 90 74 179
NOVOLIN R 89 89 76 91
PRAMIPEXOLE DIHYDROCHLORIDE 88 78 77 124
JANTOVEN 88 88 77 131
VALPROIC ACID 88 57 77 180
TRAMADOL HCL-ACETAMINOPHEN 88 81 77 180
DILTIAZEM ER 84 84 81 147
LEXAPRO 84 77 81 72
CARBAMAZEPINE 84 13 81 125
CRESTOR 83 80 84 89
MELOXICAM 82 55 85 52
ROPINIROLE HCL 82 69 85 53
TEKTURNA 79 69 87 182
PREDNISONE 78 77 88 42
COMBIVENT 76 73 89 151
BENAZEPRIL HCL 75 74 90 113
ERYPED 400 74 74 10 91 185
TIZANIDINE HCL 74 47 91 185
OXYCODONE HCL 74 55 S2 91 107
CYCLOBENZAPRINE HCL 73 15 R 94 98
DILTIAZEM 24HR CD 70 60 95 81
GLIPIZIDE 67 55 96 49
BACLOFEN 66 27 97 80
PRAVASTATIN SODIUM 65 40 98 33
PAROXETINE HCL 65 54 98 75
AMITRIPTYLINE HCL 65 55 R 98 112
RAMIPRIL 64 62 101 158
LYRICA 64 40 101 110
OXYBUTYNIN CHLORIDE ER 63 57 103 105
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 48 104 87
DILTIAZEM HCL 61 56 105 163
ALLOPURINOL 60 60 106 50
SPIRONOLACTONE 60 49 106 57
LATANOPROST 58 58 108 131
FINASTERIDE 57 49 109 73
OLANZAPINE 56 40 110 74
TRICOR 56 31 110 170
PROAIR HFA 56 35 110 86
PRENATAL PLUS 55 39 113 145
ZIPRASIDONE HCL 54 45 114 212
VESICARE 54 50 114 115
PEN NEEDLE 54 36 114 161
LEVETIRACETAM 53 34 117 67
AZITHROMYCIN 52 34 118 83
LIPITOR 51 34 119 168
GLIMEPIRIDE 51 51 119 51
PRIMIDONE 50 42 121 146
VENLAFAXINE HCL 50 39 121 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.